Phathom Pharmaceuticals, Inc. (PHAT) has 81 open-market insider trades by 15 insiders since 2019. The most active filer is Takeda Pharmaceutical Co. Ltd., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Co. Ltd. | 10% Owner | — | 20 | $88.2M | 2024-01-24 |
| Peter Kolchinsky | 10% Owner | — | 1 | $31.1M | 2021-03-11 |
| Jonathan S. Edwards | Dir | — | 1 | $20.0M | 2019-10-29 |
| Patrick J. Heron | Dir10% Owner | — | 1 | $20.0M | 2019-10-29 |
| David A. Socks | Dir | — | 11 | $17.6M | 2024-05-23 |
| Azmi Nabulsi | COO | — | 12 | $4.5M | 2025-02-27 |
| RA Capital Healthcare Fund LP | 10% Owner | — | 1 | $2.9M | 2020-04-01 |
| Terrie Curran | CEOPres | — | 8 | $2.3M | 2025-01-21 |
| RA Capital Management, L.P. | 10% Owner | — | 1 | $1.5M | 2020-03-31 |
| Asit Parikh | Dir | — | 8 | $471K | 2026-05-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert Charles Breedlove | Principal Accounting Officer | Sell | $7K | 2025-11-03 |
| Robert Charles Breedlove | Principal Accounting Officer | Sell | $6K | 2025-09-05 |
| Robert Charles Breedlove | Principal Accounting Officer | Sell | $14K | 2025-07-16 |
| James N. Topper | Director | Buy | $15K | 2025-05-21 |
| James N. Topper | Director | Buy | $24K | 2025-05-13 |
| James N. Topper | Director | Buy | $259K |
Companies that share insiders with PHAT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-05-09 |
| Asit Parikh | Director | Buy | $25K | 2025-05-06 |
| Molly Henderson | CFO and CBO | Sell | $17K | 2025-04-07 |
| Asit Parikh | Director | Buy | $44K | 2025-03-13 |
| Molly Henderson | CFO and CBO | Sell | $43K | 2025-01-21 |
| Terrie Curran | CEO & President | Sell | $252K | 2025-01-21 |
| Azmi Nabulsi | COO | Sell | $104K | 2025-01-21 |
| Molly Henderson | CFO and CBO | Sell | $10K | 2024-12-19 |
| Azmi Nabulsi | COO | Sell | $9K | 2024-12-19 |
| Asit Parikh | Director | Buy | $162K | 2024-12-13 |